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RNA editing in kinetoplastid mitochondria occurs by a series of enzymatic steps that is catalyzed by a
macromolecular complex. Four novel proteins and their corresponding genes were identified by mass spec-
trometric analysis of purified editing complexes from Trypanosoma brucei. These four proteins, TbMP81,
TbMP63, TbMP42, and TbMP18, contain conserved sequences to various degrees. All four proteins have
sequence similarity in the C terminus; TbMP18 has considerable sequence similarity to the C-terminal region
of TbMP42, and TbMP81, TbMP63, and TbMP42 contain zinc finger motif(s). Monoclonal antibodies that are
specific for TbMP63 and TbMP42 immunoprecipitate in vitro RNA editing activities. The proteins are present
in the immunoprecipitates and sediment at 20S along with the in vitro editing, and RNA editing ligases
TbMP52 and TbMP48. Recombinant TbMP63 and TbMP52 coimmunoprecipitate. These results indicate that
these four proteins are components of the RNA editing complex and that TbMP63 and TbMP52 can interact.
RNA editing in trypanosomes posttranscriptionally inserts
and deletes uridylates (U’s) at multiple sites in most mitochon-
drial pre-mRNAs to produce mature mRNAs. U insertion and
deletion are directed by guide RNAs (gRNAs) and are cata-
lyzed by a macromolecular complex. Editing occurs by a series
of enzymatic steps that include endoribonuclease, 3 terminal
uridylyl transferase (TUTase), 3 exouridylylase, and RNA li-
gase activities (reviewed in references 3, 8, 21, and 23). Al-
though editing can be extensive, with the insertion and deletion
of numerous U’s, it is also very specific. The characteristics of
the enzymatic activities contribute to this specificity (7), but
noncatalytic proteins may be required for editing and may
contribute to the specificity.
RNA editing is catalyzed by a 20S ribonucleoprotein com-
plex (2, 15), and identification of its components and the com-
position of the fully functional complex is at an early stage.
Initial studies estimated that a complex that can catalyze at
least some of the steps of editing in vitro contains 7 to 20
polypeptides (11, 14, 16). Two related proteins, TbMP52 and
TbMP48, were identified by mass spectrometric analysis of
purified editing complexes (14), and TbMP52 was shown to be
essential for RNA editing and for survival of bloodstream
forms in vivo and in vitro (19). In addition, TbMP52 and
TbMP48 correspond to the larger and smaller adenylatable
proteins in the RNA editing complex, respectively, and were
found to be RNA ligases (12, 17, 19). TbMP52 corresponds to
T. brucei V and T. brucei p52 and TbMP48 corresponds to T.
brucei IV and T. brucei p48 (12, 17). The fully functional ed-
iting complex, which may consist of a catalytic core complex
and accessory and regulatory factors may contain numerous
proteins. Several other candidate proteins, some of which have
RNA binding activities, have been described and may play a
role in RNA editing (6, 9, 11, 13, 25). However, except for
mHel61p (13), none of these proteins have been shown to play
a direct role in editing.
In this study, we describe the identification of four additional
proteins that are present in the RNA editing complex by im-
munoprecipitation, mass spectrometric, and/or gradient sedi-
mentation analyses. These four proteins have sequence simi-
larities to each other and the three largest contain one or two
C2H2 zinc finger motif(s). One protein was also shown to
interact in vitro with the TbMP52 editing RNA ligase.
MATERIALS AND METHODS
In vitro editing and adenylation assays. Deletion and insertion editing were
assayed in vitro using 3-labeled A6-U5 pre-mRNA substrate with gA6[14]16G
gRNA and precleaved 5CL18 and 3CL13pp substrates with gPCA6-2A RNAs,
respectively, as previously described (7, 20). The reaction products were resolved
on polyacrylamide-urea gels and visualized on Storm PhosphorImager screens
(Molecular Dynamics). Adenylation of the editing RNA ligases was determined
as previously described (18) using 15-min incubations at 28°C with 2.5 Ci of
[-32P]ATP in 25 mM HEPES (pH 7.9)–10 mM Mg(OAc)2–50 mM KCl–0.5 mM
dithiothreitol–10% dimethyl sulfoxide. The proteins were resolved on sodium
dodecyl sulfate–10% polyacrylamide gel electrophoresis (SDS–10% PAGE) gels,
and the radiolabeled proteins were detected by phosphorimaging.
Protein and gene identification. Trypanosoma brucei procyclic cells (strain
IsTaR 1.7a) were grown to log phase in vitro (22), and the mitochondrial vesicles
were isolated (5). The editing complex was isolated by sequential ion-exchange
(SP- and Q-Sepharose) and gel filtration (Superose 6) column chromatography
(14). The proteins in the peak deletion editing fractions from Superose 6 column
were separated on an SDS–10% PAGE gel and stained with Coomassie brilliant
blue. The protein bands were excised, digested in-gel with trypsin, and analyzed
by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)
and T. brucei nucleotide database searches (reference 14 and references cited
therein). Complete open reading frames (ORFs) were determined when signif-
icant peptide matches were found to genomic sequences for which the complete
ORF was not available. The DNA fragment was amplified by PCR using primers
designed based on database analysis, was cloned, and was sequenced, and the
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ORF was identified by multiple-sequence alignment using the Seqman program
(DNASTAR, Inc.). Details of how proteins TbMP81, TbMP63, TbMP42, and
TbMP18 were identified are described in the Results. The National Center for
Biotechnology Information nonredundant protein database was searched for
homologs to the predicted protein sequences by using the BLAST algorithm, and
the PROSITE, BLOCKS, and CDD databases were searched for the presence of
known motifs and domains in the predicted proteins. Mitochondrial targeting
signals were predicted using the PSORT II algorithm (http://psort.ims.u-tokyo
.ac.jp/form2.html), and an amphiphilic helix was predicted at the N terminus of
the proteins by using Gene Runner (Hastings Software, Inc.). Amino acid re-
peats in the predicted protein sequence were identified by Dotplot analysis using
MegAlign software, and a hydrophobic region was predicted by Protean analysis
(DNASTAR, Inc). Multiple sequences were aligned using the ClustalW algo-
rithm (http://www.ebi.ac.uk/clustalw/).
Immunoprecipitation of editing complex. Monoclonal antibodies (MAbs) gen-
erated against the purified native editing complex were conjugated to anti-mouse
immunoglobulin G (IgG)-coated Immunomagnetic beads (Dynabeads M-450;
DYNAL), and immunoprecipitation from the mitochondrial 20S fraction was
performed as previously described (14). The samples bound to the beads were
directly assayed for deletion editing and precleaved insertion editing in vitro,
adenylation activity, and editing-associated enzymatic activities (14). The pri-
mary and secondary antibodies were cross-linked as described by the manufac-
turer (DYNAL) for MS analysis of the immunoprecipitated proteins. The editing
complex was then immunoprecipitated from mitochondrial lysate (14), and the
proteins were eluted from the antibody complex with 0.5 M acetic acid, pH 2.6,
and neutralized with NaOH. The eluted proteins were concentrated using Cen-
tricon-YM10 membrane (Amicon) and desalted with 10 mM Tris (pH 7.2), and
approximately 2 g of the proteins was digested with 40 ng of trypsin and
analyzed by LC-MS/MS.
Cloning and expression of TbMP63 and TbMP42. DNA corresponding to the
TbMP63 ORF was amplified from T. brucei genomic DNA with primers 3316
(TGG ATC CTC AAG ACG ATG TAC C) and 3317 (AAG GGA ATT CGG
TAT TCT CC) (restriction sites are italicized). The amplified DNA was cloned
into the pGEM-T Easy vector (Promega), and its sequence was confirmed. The
insert was released by digestion with BamHI and EcoRI and cloned into a
pRSET C vector (Invitrogen) cut with the same enzymes. Similarly, the DNA
corresponding to the TbMP42 ORF was PCR amplified with primers 3528 (AGG
ATC CAC TTG TGT TGT CGC) and 3529 (TGA ATT CTC ACA CCT TCA
ACA C) and cloned into the pRSET B vector at the BamHI-EcoRI site. Amino
acids 1 to 12 of the predicted TbMP42 protein sequence were omitted in the
resultant Tb08-pRSET construct. The plasmids were transformed into BL21
DE3-LysS cells, and recombinant proteins were expressed at 30°C with 1 mM
IPTG (isopropyl--D-thiogalactopyranoside) induction. Proteins from recombi-
nant Escherichia coli cells were separated by SDS–10% PAGE, transferred to
nitrocellulose filters, and reacted with MAbs. E. coli cells transformed with
vector only were used as a negative control.
In vitro expression of proteins. DNA corresponding to the TbMP63 ORF was
PCR amplified from T. brucei genomic DNA using primers 3602 (CTG AAT
TCG ATG TAC CGC A) and 3603 (CTG GAT CCG GTA TTC TCC CCT). The
amplified DNA was digested with EcoRI and BamHI and cloned into the EcoRI-
BamHI site of the pSG1 vector. DNA corresponding to the TbMP42 ORF was
amplified with primers 3604 (GGA ATT CAT GAA GCG TGT TAC) and 3605
(CGG GAT CCT CAC ACC TTC AAC A) and cloned into the pSG1 vector
at the EcoRI-BamHI site. Recombinant TbMP63 (rTbMP63) and TbMP42
(rTbMP42) proteins were produced in vitro using a cell-free, coupled transcrip-
tion-translation system (TNT; Promega) according to the manufacturer’s instruc-
tions. The proteins were labeled by incorporation of [35S]methionine during
translation. Recombinant TbMP52 (rTbMP52) was expressed under similar con-
ditions by using the plasmid pSG-TbMP52 (19).
Protein-protein interaction assay. Protein-protein interactions were investi-
gated by coimmunoprecipitation of in vitro-translated recombinant proteins us-
ing MAbs that were coupled to immunomagnetic beads as described above.
35S-labeled and unlabeled recombinant TbMP63 (rTbMP63), rTbMP52, and
rTbMP42 were produced in vitro. The labeled and unlabeled recombinant pro-
teins were mixed together in various combinations and immunoprecipitated with
MAbs P1H3-D7 (anti-TbMP63) or P3C1-G2 (anti-TbMP52) by using in vitro-
expressed 35S-labeled luciferase protein as negative control. The incubations and
washes were carried out at high stringency using IP500 buffer (10 mM Tris [pH
7.5], 5 mM EDTA, 500 mM KCl, 0.5% Triton X-100, 1% bovine serum albumin).
The immunoprecipitated samples were digested and resolved on SDS–10%
PAGE gels, and the labeled proteins were detected by phosphorimaging.
Nuclease treatment and Western analysis. Fifty-microliter samples of pooled
glycerol gradient fractions from the peak of in vitro editing activity were treated
for 30 min at 25°C with either 20 g of RNase A or a mixture of RNases
(DNase-free RNase; Boehringer Mannheim). Mock treatment was carried out
with buffer alone (10 mM Tris [pH 7.2], 10 mM MgCl2, 5 mM CaCl2, 50 mM
KCl). Following the treatment, the samples were immunoprecipitated with anti-
TbMP63 MAb in immunoprecipitation (IP) buffer (10 mM Tris [pH 7.2], 10 mM
MgCl2, 200 mM KCl, 0.1% Triton X-100). These immunoprecipitates were
resolved on SDS–10% PAGE gels, transferred to polyvinylidene difluoride mem-
branes, and examined by Western analyses using MAbs specific for TbMP81,
TbMP63, TbMP52, and TbMP42 that were generated against the native editing
complex as previously described (14). Total mitochondrial lysates, glycerol gra-
dient (10 to 30%) fractions of these lysates, and recombinant proteins were
subjected to similar Western analyses.
Nucleotide sequence accession numbers. The nucleotide sequences have been
submitted to GenBank with accession numbers AF382333, AF382334, AF382335,
and AF382336.
RESULTS
Identification of TbMP81, TbMP63, TbMP42, and TbMP18.
Four proteins and their corresponding genes were identified by
high-performance LC-MS/MS analysis of protein bands from
purified editing complexes (14). Fractions containing the peak
editing activities from sequential SP-Sepharose, Q-Sepharose,
and Superose 6 column chromatography were concentrated
and separated on an SDS–10% PAGE gel. Coomassie blue-
stained bands that correspond to those in most purified frac-
tion (14) (see Fig. 2) were excised and analyzed by LC-MS/MS.
Comparison of the MS/MS data from the 99-kDa protein
band to data in T. brucei DNA sequence databases identified
15 tryptic peptides that match those in a protein encoded by a
2,289-nucleotide ORF in The Institute of Genomic Research
(TIGR) T. brucei database [positions 12616 to 14904, GenBank
accession no. (gb) AC008031.3, chromosome II, clone RPCI93-
25N14]. The predicted preprocessed protein has 762 amino
acids and a mass of 81 kDa; hence, the protein was designated
TbMP81.
Similar analysis of the 69-kDa protein band did not iden-
tify a complete ORF but revealed MS/MS matches to several
DNA sequences, allowing us to identify and sequence the
complete gene as described below. The analysis identified
three tryptic peptides, (K)PLHQPDR, (R)TFVDEEER, and
(K)LHLQQAHGGDGSVEAGPGPGVEASSVNVVNTPVPS
PISPVER, that match peptides predicted from T. brucei genomic
DNA clone G654 (gb B07464). It also identified tryptic peptides
(R)LHPVYEASNNK in genomic DNA clone G432 (gb B07352),
(K)PLQPPQPK in genomic DNA clone 37L1.TR (TIGR data-
base, gb AQ950249), and (R)LEGNFVHSTMVMK and (K)
PLQPPQPK in genomic DNA clone 16E22.TF (TIGR database,
gb AQ650728). Furthermore, the nucleotide sequence of clone
G654 matched that of EST clone T651 (EMBL accession no.
T26253). cDNA clone T651 was completely sequenced and found
to overlap with the sequences of the above genomic DNA clones,
suggesting that the identified peptides correspond to a single
protein. The 5 region of the ORF, which was not in the DNA
sequence databases, was amplified by PCR, cloned, and se-
quenced. It was amplified using two primers (GCT CGC TTG
TGC ATG TTG and CGC AGC AAA CAC CTT CAT CAC)
that were based on 5- and 3-end sequences from DNA clone
16E22. The complete ORF sequence was assembled using these
sequences and additional matching genomic DNA sequences
(110F8.TR [gb AZ215909], 115A2.TF [gb AZ214294], 115A2.TR
[gb AZ214297]) that were identified in the databases. The com-
plete ORF was then PCR amplified from T. brucei genomic
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DNA, cloned, and sequenced. The 1,767-nucleotide ORF pre-
dicts a 588-amino-acid protein with a mass of 63 kDa, and the
protein was designated TbMP63.
LC-MS/MS analysis of the 45-kDa protein identified two
tryptic peptides, (R)LINALNHHIMTK and (K)LEEVNPEEIK,
corresponding to genomic DNA clone 34C8.TF (TIGR data-
base, gb AQ943880) and two other tryptic peptides, (R)VFDS
DYSSR and (R)DGEWFLVTGR, corresponding to genomic
DNA clone 35I8.TF (TIGR database, gb AQ941226). Further
database analysis showed that the sequences of these two
clones overlap and that they represent a single ORF. The
sequences overlapped with four other genomic DNA clones
from the TIGR database [105A1.TR, 70B2.TR, 25O15.TR (gb
AQ655403), 11 M2.TR (gb AQ661213)]. The complete ORF
sequence (1,182 nucleotides long) was assembled from these
sequences. The ORF was predicted to encode a 393-amino-
acid protein with a mass of 42 kDa, which was designated
TbMP42.
Analysis of the 22-kDa protein band identified four
tryptic peptides, (R)CFGELFSAEVK, (K)EGNVVCVNGR,
(R)LSPQLEPSCNK, and (R)TVPAAVNPAVEDIK, corre-
sponding to genomic DNA clone 15K6.TR (TIGR database,
gb AQ660117). This clone overlaps with another genomic
DNA clone, 15 M18.TR (TIGR database, gb AQ649021). This
identified a 495-nucleotide ORF that encodes a 164-amino-
acid, 18-kDa protein, which was designated TbMP18. The
identity of TbMP18 was further confirmed by N-terminal
amino acid sequencing. Microsequencing of the first 23 amino
acids of native TbMP18 identified peptide sequence XKSVNS
VTLVGVVHDIQSGFVYE, which matches amino acids 19 to
41 of the predicted TbMP18 sequence. This suggests that the
first 18 amino acids form the mitochondrial import signal.
Sequence comparisons. The proteins TbMP81, TbMP63,
TbMP42, and TbMP18 are predicted to localize in mitochon-
dria by PSORT II analysis and since the amino acids at the N
terminus in all these four proteins can fold into an amphiphilic
helix (results not shown). BLAST searches to National Center
for Biotechnology Information nonredundant protein database
FIG. 1. Sequence relationships among TbMP81, TbMP63, TbMP42, and TbMP18 proteins. (A) Diagram showing N-terminal amphipathic
helices that are likely mitochondrial targeting signals (black and white) and conserved C-terminal domains (cross-hatched). C2H2 Zn finger and
Zn finger like motifs (black boxes) and SPF repeats (vertical hatched) are labeled accordingly. The thin lines indicate gaps in the sequence. Shaded
regions in TbMP18, TbMP42, and TbMP81 show sequence similarity, and horizontal hatched boxes represent similar regions between TbMP81,
TbMP63, and TbMP42 sequences. The central regions of TbMP81 and TbMP63 have a low level of sequence similarity. (B) SPF tripeptide repeats
in TbMP63. The six-unit repeat begins with amino acid 315, and the single repeat begins with amino acid 466. (C) Shown are sequences of the C2H2
Zn finger motifs, and the locations of the protein sequence are in parentheses. (D) Amino acid sequence alignment of TbMP18 (amino acids 19
to 131), TbMP42 (amino acids 286 to 393), TbMP63 (amino acids 523 to 588), and TbMP81 (amino acids 695 to 762). Indicated are amino acid
identity (), conservation (:), and similarity(.).
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revealed no proteins related to TbMP81, TbMP63, TbMP42,
and TbMP18, indicating that they are novel. Motif and domain
analyses identified one zinc finger motif in TbMP81 (amino
acids 207 to 228), two in TbMP63 (amino acids 61 to 82 and
411 to 432) and two in TbMP42 (amino acids 53 to 74 and 183
to 204) (Fig. 1A). No known motifs or domains were identified
in TbMP18. Dotplot analysis of TbMP63 identified six serine-
proline-phenylalanine (SPF) tripeptide repeats, each sepa-
rated by five to eight amino acids (amino acids 316 to 368), and
another SPF sequence (amino acids 467 to 469) separated
from the first cluster by 90 amino acids which contain a zinc
finger motif (Fig. 1A and B). The repeat region predicts a
hydrophobic domain in the protein. All of the zinc finger mo-
tifs have the signature C2H2 zinc ligands (Fig. 1C). As illus-
trated in Fig. 1A, all four proteins have sequence similarity
between them in various regions. TbMP18 has considerable
similarity to the C-terminal region of TbMP42 with 41% iden-
tity and 60% similarity over 108 amino acids (Fig. 1D), but
TbMP18 contains an additional 34-amino-acid C-terminal se-
quence. All four proteins, TbMP81, TbMP63, TbMP42, and
TbMP18, have sequence similarity in the C-terminal portion
(65- to 67-amino-acid region), with six amino acid positions
being identical. However, 15 amino acids are identical in
TbMP81, TbMP42, and TbMP18, which are more closely re-
lated to each other than to TbMP63. Pairwise sequence com-
parisons showed additional sequence relationships between
the three largest proteins. All three proteins have a domain
near the N terminus which contains a zinc finger motif that is
related, although the ones between TbMP81 and TbMP42 are
more closely related than those between TbMP63 and these
other two proteins. TbMP81, however, has an additional N-
terminal sequence. The C-terminal region of TbMP42 that is
similar to TbMP81 contains a zinc finger motif, while TbMP81
has a zinc finger-like motif with an insertion of 22 amino acids
in this region. TbMP63 contains a zinc finger motif in its
C-terminal region. The central regions of TbMP81 and
TbMP63 have a low level of sequence similarity.
Association of TbMP81, TbMP63, TbMP42, and TbMP18
with RNA editing complex. The association of the proteins with
the editing complex was assessed by the ability of MAbs against
FIG. 2. Western analysis showing the reactions of MAb P1H3-D7
with native and recombinant TbMP63 and of MAb P3C12-D8 with
native and recombinant TbMP42. E. coli cells transformed with vector
alone were used as negative control. Recombinant TbMP63 and
TbMP42 containing an N-terminal His6 tag were expressed in E. coli
cells.
FIG. 3. Immunoprecipitation analyses of editing complex. (A) In
vitro deletion editing assay of immunoprecipitates from the mito-
chondrial 20S fraction using MAbs against () TbMP81, TbMP63,
TbMP52, and TbMP42. Input pre-mRNA and the edited RNA, chi-
meras, and 3-cleavage product that result from editing activities are
indicated. Anti-pyruvate dehydrogenase subunit E2 MAb ( PDH)
was used as negative control antibody, and the 20S fraction from
glycerol gradient-separated mitochondrial extract with (GG extract)
and without (no gRNA) gRNA served as positive and negative con-
trols, respectively, for the editing assay. (B) In vitro-precleaved inser-
tion editing assays of samples and controls (except for no gRNA) as in
panel A. The input 5-labeled 5 substrate RNA and the product with
two added Us are ligation products of the input substrate RNA and
unlabeled 3 substrate RNA and the accurately edited RNA product.
Products with one added U and the product of its ligation with the 3
substrate RNA are not labeled. (C) Adenylation assay of samples and
controls as in panel B. The adenylated native 50-kDa TbMP52 and
45-kDa TbMP48 RNA ligases are labeled. The 50-kDa adenylated
protein band in the  PDH negative control lane was also detected
with other nonspecific antibodies, and this was due to nonspecific
binding.
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specific proteins to precipitate editing activities from mito-
chondrial lysate and detection of these proteins in the affinity-
purified editing complex. MAbs P1H3-D7 and P3C12-D8, re-
spectively, which were generated against the isolated editing
complex (14), specifically reacted with both native and recom-
binant TbMP63 and TbMP42 proteins (Fig. 2). The MAbs did
not cross-react with any other proteins in the mitochondrial
lysate. Both antibodies immunoprecipitated in vitro deletion
editing, precleaved insertion editing, and adenylation activities
from the mitochondrial 20S fraction (Fig. 3). A MAb that is
specific for TbMP52, an RNA ligase that has been shown to be
essential for editing (19), also immunoprecipitated these activ-
ities. The lower adenylation activity with the anti-TbMP52
MAb relative to that of the anti-TbMP63 and anti-TbMP42
MAbs reflected inhibition of the adenylation by the anti-
TbMP52 MAb. In contrast, MAbs that are specific for the E2
subunit of pyruvate dehydrogenase (MAb 58) and ATP syn-
thase  (MAb P7D9-A12) did not precipitate editing activities
(14). Thus, TbMP63 and TbMP42 are tightly associated with
and are likely components of the editing complex.
MAb P4D8-F6, which was also generated using native edit-
ing complexes, is specific for TbMP81. It specifically reacts with
the native protein (Fig. 4A and B, top band) and recombinant
protein which was expressed in vitro after cloning into the
eukaryotic expression vector pSG1 (data not shown), since we
were unable to express the protein in E. coli cells. This MAb
immunoprecipitated precleaved insertion editing and adenyla-
tion activities from the 20S fraction of the mitochondrial lysate
(Fig. 3B and C). The lower level of adenylation activity relative
to the anti-TbMP63 and anti-TbMP42 MAb precipitates is due
to relatively less protein in the precipitate as determined by
Western analysis (results not shown). Neither in vitro deletion
RNA editing nor endonucleolytic cleavage of the input pre-
mRNA substrate was detected in the immunoprecipitate (Fig.
3A). The presence of both the 50- and 45-kDa adenylatable
proteins in the immunoprecipitate (Fig. 3C), which correspond
to TbMP52 and TbMP48, respectively (12, 19), provides evi-
dence that TbMP81 is present in the editing complex along
with TbMP63 and TbMP42. Comparable studies were not pos-
sible for TbMP18 since no suitable MAb is available.
Additional studies showed that TbMP81, TbMP63, TbMP42,
and TbMP18 cosediment and/or coimmunoprecipitate with
each other, with editing complex ligases, and with in vitro
editing activity. Western analysis of glycerol gradient-fraction-
ated mitochondrial lysate showed that the bulk of the native
TbMP81, TbMP63, and TbMP42 proteins cosediment together
at 20S along with TbMP52 (Fig. 4A), which has been shown
to be an essential part of the editing complex (14, 19). Anti-
TbMP63 MAb (P1H3-D7) was used to precipitate the editing
complex from either crude or glycerol gradient-fractionated
mitochondrial lysate. Western analysis identified TbMP81,
TbMP63, TbMP52, and TbMP42 proteins in the immunopre-
cipitated sample (Fig. 4B). In addition to these proteins, MS
analysis of the immunoaffinity-purified complex identified
TbMP48 (RNA ligase) and TbMP18 in the complex.
Nuclease treatment of complex. The mitochondrial 20S frac-
tion from glycerol gradients was treated with RNases and the
complex was immunoprecipitated with anti-TbMP63 MAb as
described in Materials and Methods. Western analysis of the
precipitated sample showed that the three zinc finger proteins
were still associated with a complex following RNase treat-
ment, as was RNA editing ligase TbMP52. No significant quan-
titative difference was observed between RNase-treated and
mock-treated sample (Fig. 5). Despite extensive washing traces
of RNase remained in the precipitated sample, which upon
incubation with editing substrates degraded most of the RNA.
Hence, we were unable to assess whether the RNase treatment
affected editing associated enzymatic activities.
TbMP63 binds to TbMP52 in vitro. Coimmunoprecipitation
analyses showed that TbMP63 and TbMP52 can interact. Anti-
TbMP63 MAb precipitated rTbMP52 only in the presence of
rTbMP63, and similarly, anti-TbMP52 MAb specifically pre-
cipitated rTbMP63 upon coincubation with rTbMP52 (Fig. 6),
indicating these two proteins bind to each other. Anti-TbMP63
MAb did not precipitate TbMP52 when present alone nor did
anti-TbMP52 MAb precipitate TbMP63 alone. The binding
FIG. 4. Western analyses of sedimented and immunoprecipitated
editing complexes. (A) Analysis of glycerol gradient fractions from
cleared mitochondrial lysate. The top of the gradient is fraction 1. (B)
Analysis of editing complexes that were immunoaffinity purified from
the 20S fraction by using a MAb specific for TbMP63.
FIG. 5. Western analysis of RNase treated editing complexes, using
the panel of MAbs that are specific for the indicated proteins. The
complexes were immunoprecipitated with a MAb specific for TbMP63.
Pooled 20S fractions of cleared mitochondrial lysate were treated with
RNase or mock treated as described in Materials and Methods. The
anti-TbMP63 MAb that was used for immunoprecipitation and which
reacts with the second antibody in the Western analysis is indicated.
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reactions and washes were carried out under highly stringent
conditions, and the luciferase control did not coprecipitate
with these proteins nor did anti-His6 MAb pull down the pro-
teins (results not shown), indicating that the interaction be-
tween TbMP52 and TbMP63 was specific. Under similar con-
ditions TbMP81 did not coprecipitate with these proteins and
no other specific interactions were observed among TbMP42,
TbMP48, TbMP52, and TbMP63 (results not shown).
Editing complex subunit or fragment. In vitro editing and
most of the associated catalytic activities elute at 1,600 kDa
(peak I) from Superose 6 columns during purification of the
editing complex, but some of the activities elute at 450 to 500
kDa (peak II) (11, 14). The peak I sediments at 20S (14) and
peak II sediments have not been tested due to low abundance
but may sediment at less than 20S. In vitro deletion editing was
not detected in material that was immunoprecipitated with
anti-TbMP63 MAb from peak II although it was detected in
peak I immunoprecipitates (data not shown). In addition,
there was less precleaved insertion editing activity and U ad-
dition activity but a greater ratio of ligated-to-edited RNA in
peak II than in peak I immunoprecipitates (Fig. 7A). Thus, the
peak II immunoprecipitate contains TUTase and ligase activ-
ities although apparently less than in immunoprecipitates from
peak I. Western analysis of these samples showed that while
the TbMP81, TbMP63, and TbMP42 zinc finger proteins are
present in the immunoprecipitate from peak I, the former two
but not TbMP42 was detected in immunoprecipitates from
peak II (Fig. 7B). In addition, while adenylatable TbMP52 and
TbMP48 RNA ligases were present in immunoprecipitates
from peak I, adenylatable TbMP48 was not detected in immu-
noprecipitates from peak II (Fig. 7C). Thus, peak II appears to
contain some but not all of the components of the editing
complexes that are present in peak I.
DISCUSSION
This study describes the identification of four proteins from
purified RNA editing complexes of T. brucei and the corre-
sponding genes which encode preprocessed proteins with
masses of 81, 63, 42, and 18 kDa. All four proteins contain a
similar C-terminal domain, and the 42- and 18-kDa proteins
have considerable sequence similarity. In addition, the 81-kDa
protein contains a single zinc finger motif while the 63- and
42-kDa proteins each contain two zinc finger motifs. All four
proteins were shown, by a combination of Western and MS
analyses, to be present along with two editing RNA ligases in
functional editing complexes. These complexes were specifi-
cally immunoprecipitated from total mitochondrial lysate, the
20S fraction of glycerol gradients, and the 1,600-kDa fraction
from Superose 6 columns. These immunoprecipitation studies
used MAbs that were prepared with native complex proteins
and are specific for the 81-, 63-, and 42-kDa proteins, as well as
the 52-kDa editing RNA ligase. Coimmunoprecipitation stud-
ies using these MAbs showed that the 63- and 52-kDa editing
RNA ligase recombinant proteins interact. We conclude that
these four proteins along with the 48- and 52-kDa RNA ligases
are components of the RNA editing complex of T. brucei and
that the 52- and 63-kDa proteins may be in contact in the
complex.
The proteins were identified by MS, which has become an
important proteomic tool (reviewed in reference 4). Identifi-
cation of the proteins and their corresponding genes in the
public databases by computational means was possible despite
the fact that the genome sequencing of T. brucei is not yet
complete but is predominantly composed of end sequences of
FIG. 6. Autoradiogram of SDS-PAGE analysis of coimmunopre-
cipitation analyses of TbMP63 and TbMP52 recombinant proteins.
The protein that was radiolabeled in each reaction is indicated (), and
the 52-kDa (a) and 63-kDa (b) proteins that were coimmunoprecipi-
tated are shown.
FIG. 7. Analyses of complexes with different molecular masses.
Complexes were immunoprecipitated with anti-TbMP63 MAb from
Superose 6 column fractions that correspond to 1,600 kDa (I) and 500
kDa (II) after sequential chromatography with SP Sepharose and Q
Sepharose columns. (A) In vitro precleaved insertion editing assay of
immunoprecipitates labeled as in Fig. 2B. (B) Western analysis of the
immunoprecipitates using MAbs specific for the proteins indicated.
Note the absence of TbMP42 in II. (C) Adenylation analysis of the
immunoprecipitates revealing the lack of adenylated TbMP48 in II.
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clones from genomic DNA libraries. This was accomplished by
reiterative comparisons among mass spectrometric and DNA
sequence data and, finally, PCR amplification, cloning, and
sequencing of the complete gene. The confirmation of gene
identity in all cases illustrates the reliability of this approach.
Gene identity was confirmed by specific reaction of native and
recombinant 81-, 63-, and 42-kDa proteins with MAbs that
were generated against the isolated complex and by the match
between the N-terminal sequences of the 18-kDa protein se-
quence and the gene identified by LC-MS/MS.
Several lines of evidence lead to the conclusion that the four
proteins identified in this study are components of the RNA
editing complex along with the TbMP52 and TbMP48 RNA
ligases. These proteins cofractionate with in vitro deletion and
insertion editing, their component catalytic activities, and the
52- and 48-kDa editing RNA ligases, all of which ultimately
elute from Superose 6 columns at 1,600 kDa and sediment at
20S in glycerol gradients (14) (Fig. 4A). In addition, all six
proteins were detected by Western or MS/MS analysis in com-
plexes that were immunoprecipitated with MAbs specific for
these proteins and for the 52-kDa editing RNA ligase (Fig. 3
and 4). They were not immunoprecipitated by MAbs specific
for mitochondrial proteins from the ATP synthase and pyru-
vate dehydrogenase complexes that did not cosediment with
the RNA editing complex. The immunoprecipitations were
performed and washed under stringent conditions (i.e., in
buffer containing up to 400 mM KCl), which should dissociate
adsorbed proteins from the immunoprecipitated complexes
(14). RNase treatment, which would have eliminated proteins
present as a result of RNA binding proteins, did not eliminate
immunoprecipitations of proteins that could have been assayed
with the available MAbs.
The potential functions of the four proteins identified in this
study are not evident from homology searches. The C2H2 zinc
finger motifs found in the 81-, 63-, and 42-kDa proteins imply
that these proteins may have roles in nucleic acid or protein
binding. Such motifs are common in eukaryotes and can func-
tion in DNA binding for gene regulation (1, 26) or protein-
RNA and protein-protein interactions (10). These motifs may
bind the pre-mRNAs and gRNAs that are present in purified
editing complexes (11, 14) and that associate with the complex
during editing and/or bind proteins to the editing complex. The
demonstration in this study that TbMP63 can bind to TbMP52
(Fig. 6) is suggestive of a protein binding role. The finding that
nuclease treatment did not dissociate the zinc finger or 52-kDa
editing RNA ligase from an immunoprecipitable complex (Fig.
5A) suggests that RNA that is accessible to the nuclease deg-
radation (some RNA resists degradation [24]) is not essential
for overall complex integrity. Thus, the zinc finger proteins
may play a role in the structural organization, integration of
catalytic functions, and/or regulatory functions of the editing
complex. The SPF tripeptide repeats in the 63-kDa protein are
the only other evident motif which may be important for the
structure and thereby the function of this protein.
The four editing complex proteins identified here may have
a variety of functions in addition to molecular binding, includ-
ing catalytic activity. The MAb specific for the 81-kDa protein
immunoprecipitated precleaved insertion editing, revealing
TUTase and RNA ligase activities, but the RNA substrate was
not cleaved, suggesting the absence of endoribonuclease activ-
ity in the immunoprecipitate (Fig. 3). Preliminary results by
Salavati and Drozdz et al. (unpublished results) suggest that
the TbMP81 protein is associated with endonuclease activity.
The relationship between the 81-kDa protein and the other
three proteins implies that they may have comparable roles,
and the substantial similarity between the C-terminal portion
of the 42-kDa protein and the 18-kDa proteins implies that
they may have substantially similar functions. It is uncertain
from our results if all four proteins are derived from an ances-
tral protein by sequence divergence following gene duplication
or if some are derived by modification via domain switching.
Genetic studies are in progress to assess which of the proteins
are essential to editing and to identify their functions.
The total composition of the fully functional editing complex
is uncertain. Functional editing complexes have been biochem-
ically prepared from T. brucei by different methods (11, 14, 16).
Purification was monitored by tracking RNA ligase adenyla-
tion (11, 16) or in vitro editing plus associated editing activities,
including RNA ligase adenylation (14). The complexes pre-
pared in the Sollner-Webb lab (16) appear to lack RNA and
contain seven major proteins while those prepared for this
study (14) and in the Hajduk lab (11) contain mRNA and
gRNA and 20 or more major proteins. Proteins designated IV
and V by the Sollner-Webb lab correspond, respectively, to the
TbMP52 (T. brucei p52) and TbMP48 (T. brucei p48) editing
RNA ligases (12, 17, 19). Based on electrophoretic mobility,
proteins II, III, and VII may correspond to the 81-, 63-, and
18-kDa proteins identified here, respectively, and proteins I
and VI may correspond to previously observed 99- and 44-kDa
proteins (14) that we also detected in MAb affinity-purified
complexes (24). The proteins in complexes purified in the
Hajduk lab (11) have similar electrophoretic mobilities but
different relative silver staining intensities compared to those
used here. This suggests differences in relative abundance
and/or presence of various proteins, including contaminants in
the preparations. Consequently, except for editing ligases, we
could not identify likely corresponding proteins.
The purified complex preparations described above are able
to edit a single site as specified by a gRNA. However, fully
functional in vivo complexes edit numerous sites and use mul-
tiple gRNAs, indicating the need for additional functions, such
as pre-mRNA translocation and gRNA replacement. It seems
likely that there is a core catalytic complex with the endonu-
clease, TUTase, exo-Uase, and RNA ligase catalysts. As shown
here, the 81-, 63-, and 52-kDa (RNA ligase), 48-kDa (RNA
ligase), and 42- and 18-kDa proteins are stable components of
a complex that catalyzes gRNA-directed editing at a single site.
These proteins, along with the 99-kDa protein (24), may cor-
respond to the complexes purified in the Sollner-Webb lab (16)
which catalyze deletion and insertion editing. While this sug-
gests that the five non-RNA ligase proteins have the endonu-
clease, exoUase, and TUTase activities, the presence of other
proteins with these activities in low abundance cannot yet be
excluded. In addition, 61-kDa (RNA helicase) and 55-, 53-,
47-, 44-, and 24-kDa proteins are also associated with the
complex (references 14 and 24 and unpublished data). These
latter six proteins may vary in the stability of their association
with the complex, and this may be affected by the presence of
RNA. The Simpson lab has identified a gene for a 1,120-
amino-acid protein (130 kDa) with TUTase activity from L.
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tarentolae and its homologous gene from T. brucei (L. Simpson,
personal communication). Since a protein of this size was not
detected in the complexes described here, this may indicate
that there may have been multiple editing TUTases, that TUT-
ase was present in low abundance in our preparations, or that
it was not the editing TUTase but perhaps an enzyme that
added U tails to gRNA.
Functional analyses of the components of the editing com-
plex are at an early stage. An RNA helicase, mHel61p, appears
to have a nonessential role in editing since null mutants edit,
but with reduced activity (13). Perhaps there is another editing
RNA helicase that compensates for mHel61p in the null mu-
tants. The TbMP52 RNA ligase is essential to editing (19)
while the related TbMP48 is not essential to editing (24). Thus,
TbMP52 may compensate for the loss of TbMP48 but TbMP48
may not compensate for the loss of TbMP52. The significance
of this functional redundancy is unclear. The presence of four
related proteins, two of which have a region of substantial
similarity, is a further indication of such potential redundancy.
Furthermore, the tetrameric organization of 20S complexes
from the 1,600-kDa Superose 6 peak of an editing complex
preparation (24) implies a higher order of functional redun-
dancy in which the monomers may contain proteins with sim-
ilar functions, although not necessarily the same proteins. The
500-kDa complexes from Superose 6 (14) contain TUTase and
ligase activities and the 81- and 63-kDa zinc finger proteins,
but not 42-kDa zinc finger protein and perhaps not adenylat-
able TbMP48 RNA ligase (Fig. 7). These complexes may rep-
resent subunits, assembly intermediates, or dissociated frag-
ments of the editing complex. The definitive identification of
components of the RNA editing complex with clear roles in
editing promises to accelerate progress in determining the
composition of the fully functional complex and the functions
of its components. This information along with an understand-
ing of the structural organization of the complex will be essen-
tial to elucidate how pre-mRNAs undergo extensive but accu-
rate sequence remodeling by RNA editing.
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